Most Recent

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

0 Comments

image: Opinion: Does Social Media “Like” Conservation?

Opinion: Does Social Media “Like” Conservation?

By , , and | April 8, 2013

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

3 Comments

image: Opinion: Biodiversity Impacts Humanity

Opinion: Biodiversity Impacts Humanity

By | February 20, 2013

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

2 Comments

image: Opinion: Paradoxical Amphibians

Opinion: Paradoxical Amphibians

By | February 7, 2013

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

0 Comments

image: Opinion: Fishy Deaths

Opinion: Fishy Deaths

By | October 29, 2012

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

1 Comment

image: Opinion: Controlling Invasion

Opinion: Controlling Invasion

By | October 15, 2012

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech